U.S. Point-of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report Test Location, By Application (Infectious Diseases, Oncology, Prenatal Testing), By Technology (PCR, Sequencing), By End-use, And Segment Forecasts, 2024 - 2030

Market Segmentation

• U.S. Point-of-Care Molecular Diagnostics Application Type Outlook (Revenue in USD Million, 2023 - 2030)
  • Infectious Diseases
    • HIV POC
    • Clostridium difficile POC
    • HBV POC
    • Pneumonia or Streptococcus associated infections
    • Respiratory syncytial virus (RSV) POC
    • HPV POC
    • Influenza/Flu POC
    • HCV POC
    • MRSA POC
    • TB and drug-resistant TB POC
    • HSV POC
    • Other Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Other Applications
  • Devices
• U.S. Point-of-Care Molecular Diagnostics Test Location Outlook (Revenue in USD Million, 2023 - 2030)
  • OTC
  • POC
• U.S. Point-of-Care Molecular Diagnostics Technology Outlook (Revenue in USD Million; 2023 - 2030)
  • PCR-based
  • Genetic Sequencing-based
  • Hybridization-based
  • Microarray-based
• U.S. Point-of-Care Molecular Diagnostics End-use Outlook (Revenue in USD Million, 2023 - 2030)
  • Decentralized Labs
  • Hospitals
  • Home-care
  • Assisted Living Healthcare Facilities
  • Other uses

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2023 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance